Pfiz­er inks an ear­ly-stage col­lab­o­ra­tion deal as it in­vests in an­oth­er start­up; Stem cell start­up lands car­diac tech

A busy Pfiz­er is part­ner­ing with South San Fran­cis­co-based Ab Ini­tio Bio­ther­a­peu­tics on the dis­cov­ery of new GPCR ac­ti­va­tor drugs. Pfiz­er is in­vest­ing in the com­pa­ny as part of this col­lab­o­ra­tion and hand­ing over a deal that in­cludes an un­spec­i­fied up­front as well as mile­stones. Just a cou­ple of days ago Pfiz­er helped launch a new on­colyt­ic virus biotech in Alame­da, CA dubbed Ig­nite. The phar­ma gi­ant took a 50% stake in that up­start.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER